Limitation of Infarct Size

Pathogenesis and Pathophysiology of Coronary Occlusion.- Can Infarct Size Be Limited? Prospects for "Injury-Delaying" Therapy.- Pathophysiology of Evolving Myocardial Infarction.- The Pathogenesis of Thrombosis in Human Atherosclerotic Coronary Arteries.- Thrombogenesis and Vascular Occlusion.- Evaluation of Myocardial Perfusion by Means of Contrast Echocardiography.- Discussion (edited by R. Parratt).- Limitation of Infarct Size by Nonthrombolytic Drugs.- Estimation of Acute Infarct Size In Vivo.- Pharmacology of Cardioprotection.- Calcium Antagonists and Ischaemia: A Critical Evaluation.- Can Myocardial Infarction Be Prevented or Limited by Nonthrombolytic Drugs?.- Newer Aspects of Drug Therapy: Free Radical Scavengers.- Stimulation of Vascular Prostacyclin Formation by Defibrotide: A New Strategy for Treatment of Acute Myocardial Ischaemia.- Discussion (edited by P. Lichtlen).- Limitation of Infarct Size by Thrombolytic Therapy.- Thrombolytic Therapy: State of the Art.- Early and Prehospital Thrombolytic Therapy in Acute Myocardial Infarction.- Status of Thrombolytic Therapy in Acute Myocardial Infarction in France.- Adjuvant Therapy for Coronary Reperfusion in Evolving Acute Myocardial Infarction.- Perspectives on Newer Thrombolytic Agents.- Discussion (edited by F. C. Dougherty).- Follow-up Therapy after Thrombolysis.- Is Immediate Angioplasty Required to Restore Coronary Blood Flow at Rest After Recanalisation with Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients with Acute Myocardial Infarction?.- Angioplasty After Thrombolysis: Early and Late Angiographic Results.- PTCA in Acute Myocardial Infarction.- What is the Place of Surgery Soon After Thrombolysis?.- The Use of Cardiovascular Drugs Following Thrombolysis in Humans.- Discussion (edited by F. C. Dougherty).- Prevention of Occlusion or Reocclusion.- Factors Influencing the Rate of Coronary Artery Occlusion and Reocclusion.- Which Antithrombotic Therapy Has Proven Most Effective for